CN101112360B - 大蒜素脂肪乳注射液及其制备工艺 - Google Patents
大蒜素脂肪乳注射液及其制备工艺 Download PDFInfo
- Publication number
- CN101112360B CN101112360B CN2006100197706A CN200610019770A CN101112360B CN 101112360 B CN101112360 B CN 101112360B CN 2006100197706 A CN2006100197706 A CN 2006100197706A CN 200610019770 A CN200610019770 A CN 200610019770A CN 101112360 B CN101112360 B CN 101112360B
- Authority
- CN
- China
- Prior art keywords
- garlicin
- injection
- oleic acid
- recipe quantity
- allicin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002347 injection Methods 0.000 title claims abstract description 31
- 239000007924 injection Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 235000013336 milk Nutrition 0.000 title claims description 4
- 239000008267 milk Substances 0.000 title claims description 4
- 210000004080 milk Anatomy 0.000 title claims description 4
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 title abstract description 5
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 title abstract description 5
- 235000010081 allicin Nutrition 0.000 title abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 39
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 30
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 19
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 18
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 18
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000005642 Oleic acid Substances 0.000 claims abstract description 18
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- 239000000047 product Substances 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 15
- 229940046009 vitamin E Drugs 0.000 claims abstract description 15
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- 239000002960 lipid emulsion Substances 0.000 claims abstract description 14
- 239000002245 particle Substances 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000021313 oleic acid Nutrition 0.000 claims abstract description 4
- 229960002969 oleic acid Drugs 0.000 claims abstract description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 15
- 102000002322 Egg Proteins Human genes 0.000 claims description 15
- 108010000912 Egg Proteins Proteins 0.000 claims description 15
- 241000287828 Gallus gallus Species 0.000 claims description 15
- 239000000787 lecithin Substances 0.000 claims description 15
- 235000010445 lecithin Nutrition 0.000 claims description 15
- 229940067606 lecithin Drugs 0.000 claims description 15
- 210000004681 ovum Anatomy 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 12
- 235000012424 soybean oil Nutrition 0.000 claims description 12
- 239000003549 soybean oil Substances 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 11
- 229950000845 politef Drugs 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 8
- 239000003643 water by type Substances 0.000 claims description 8
- 238000004945 emulsification Methods 0.000 claims description 7
- 210000000481 breast Anatomy 0.000 claims description 6
- 238000000465 moulding Methods 0.000 claims description 6
- 239000008215 water for injection Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 abstract description 10
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 abstract description 7
- 229920001993 poloxamer 188 Polymers 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 239000012982 microporous membrane Substances 0.000 abstract description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 2
- 238000011085 pressure filtration Methods 0.000 abstract 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 abstract 1
- 230000000622 irritating effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 235000005687 corn oil Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229920001983 poloxamer Polymers 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000006184 cosolvent Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010017533 Fungal infection Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000006081 Cryptococcal meningitis Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010027209 Meningitis cryptococcal Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- -1 cost saving Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100197706A CN101112360B (zh) | 2006-07-28 | 2006-07-28 | 大蒜素脂肪乳注射液及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100197706A CN101112360B (zh) | 2006-07-28 | 2006-07-28 | 大蒜素脂肪乳注射液及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101112360A CN101112360A (zh) | 2008-01-30 |
CN101112360B true CN101112360B (zh) | 2010-09-29 |
Family
ID=39020989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100197706A Expired - Fee Related CN101112360B (zh) | 2006-07-28 | 2006-07-28 | 大蒜素脂肪乳注射液及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101112360B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590033B (zh) * | 2009-07-01 | 2012-05-09 | 北京九和药业有限公司 | 含有桉油精、柠檬烯和a-蒎烯的药物组合物脂肪乳注射液及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615828A (zh) * | 2004-09-09 | 2005-05-18 | 华中科技大学 | 大蒜素注射乳剂及其制备方法 |
CN1686090A (zh) * | 2005-04-18 | 2005-10-26 | 四川科伦药业股份有限公司 | 大蒜素注射制剂药物及其制备方法 |
CN1698753A (zh) * | 2005-05-12 | 2005-11-23 | 沈阳药科大学 | 可过滤除菌的大蒜素和大蒜油乳剂及其制备方法 |
-
2006
- 2006-07-28 CN CN2006100197706A patent/CN101112360B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615828A (zh) * | 2004-09-09 | 2005-05-18 | 华中科技大学 | 大蒜素注射乳剂及其制备方法 |
CN1686090A (zh) * | 2005-04-18 | 2005-10-26 | 四川科伦药业股份有限公司 | 大蒜素注射制剂药物及其制备方法 |
CN1698753A (zh) * | 2005-05-12 | 2005-11-23 | 沈阳药科大学 | 可过滤除菌的大蒜素和大蒜油乳剂及其制备方法 |
Non-Patent Citations (3)
Title |
---|
储晓琴.大蒜油亚微乳的研究.沈阳药科大学硕士学位论文.2004,第三章 大蒜油亚微乳的制备. * |
郭涛等.静脉注射用大蒜油亚微乳的制备.中国药学杂志40 8.2005,40(8),602-605. |
郭涛等.静脉注射用大蒜油亚微乳的制备.中国药学杂志40 8.2005,40(8),602-605. * |
Also Published As
Publication number | Publication date |
---|---|
CN101112360A (zh) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103082091B (zh) | 一种畜禽专用营养强化液及其制备方法 | |
CN102448441A (zh) | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 | |
CN102100304B (zh) | 脂溶性维生素纳米级微乳口服液及其制备方法 | |
CN102159187A (zh) | 长春花生物碱纳米乳剂注射液及其制备方法 | |
CN107441044A (zh) | 一种纳米脂肪乳剂 | |
CN107308111A (zh) | 一种含橄榄油中/长链脂肪乳注射液及其制备方法 | |
CN101703468A (zh) | 维生素e油纳米乳制剂与制备方法 | |
KR20190010212A (ko) | 레스베라트롤의 나노캡슐 제조방법 및 제조된 레스베라트롤 나노캡슐 | |
EP3253372B1 (en) | Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations | |
CN105769839B (zh) | 一种复方利多卡因药物组合物及其制备方法 | |
CN101112360B (zh) | 大蒜素脂肪乳注射液及其制备工艺 | |
CN101278912A (zh) | 汉防己甲素纳米乳注射剂及其制备方法 | |
CN104352566A (zh) | 一种水包油型复方金霉素纳米乳 | |
CN106074383A (zh) | 孕激素药物脂微球注射液及其制备方法 | |
CN101411686A (zh) | 克拉霉素亚微乳注射液及其制备方法 | |
KR101777616B1 (ko) | α-토코페롤이 포집된 나노 지질 전달체 및 이의 제조 방법 | |
CN111388419A (zh) | 阿瑞匹坦乳剂 | |
CN105560182B (zh) | 注射用卡巴他赛组合物及其制备方法 | |
CN109157549A (zh) | Egcg灵芝孢子油软胶囊及其制备方法 | |
CN102258467B (zh) | 静脉注射用缓释青蒿素及其衍生物脂肪乳的配方及制备 | |
CN105534903B (zh) | 注射用紫杉醇组合物及其制备方法 | |
Mühlebach | Basics in clinical nutrition: Drugs and nutritional admixtures | |
CN105193722B (zh) | 二巯丙醇脂肪乳注射液 | |
CN1225242C (zh) | 一种抗肿瘤药物毛兰素脂肪乳剂及其制备方法 | |
CN104352432B (zh) | 一种抗肿瘤用半边旗5f口服乳剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FUZHOU XINGHAN BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: XIE KAIZHI Effective date: 20121129 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 350004 FUZHOU, FUJIAN PROVINCE TO: 350007 FUZHOU, FUJIAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121129 Address after: 350007, building 2, No. 1, Goldman Road, Fuzhou Town, Cangshan District, Fujian, Cangshan Patentee after: Fuzhou Xinghan Biological Pharmaceutical Co. Ltd. Address before: 350004 Fujian province Fuzhou Taijiang district traffic Lu Yao Yi occupies 1-105 Patentee before: Xie Kaizhi |
|
ASS | Succession or assignment of patent right |
Owner name: FUZHOU LUJIA PHARMACEUTICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: FUZHOU XINGHAN BIOPHARMACEUTICAL CO., LTD. Effective date: 20141115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 350007 FUZHOU, FUJIAN PROVINCE TO: 350015 FUZHOU, FUJIAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141115 Address after: 350015 Torch Innovation Building 8 Productivity Promotion Center, 206 Star Road, Mawei District, Fujian, Fuzhou Patentee after: Fuzhou Lujia Medical Technology Co.,Ltd. Address before: 350007, building 2, No. 1, Goldman Road, Fuzhou Town, Cangshan District, Fujian, Cangshan Patentee before: Fuzhou Xinghan Biological Pharmaceutical Co. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100929 Termination date: 20170728 |
|
CF01 | Termination of patent right due to non-payment of annual fee |